DK0689837T3 - Antihyoerglykæmisk aktive lægemidler - Google Patents

Antihyoerglykæmisk aktive lægemidler

Info

Publication number
DK0689837T3
DK0689837T3 DK95109812T DK95109812T DK0689837T3 DK 0689837 T3 DK0689837 T3 DK 0689837T3 DK 95109812 T DK95109812 T DK 95109812T DK 95109812 T DK95109812 T DK 95109812T DK 0689837 T3 DK0689837 T3 DK 0689837T3
Authority
DK
Denmark
Prior art keywords
active drugs
prepn
hypoglycemically active
hypoglycemically
antihyperglycaemically
Prior art date
Application number
DK95109812T
Other languages
Danish (da)
English (en)
Inventor
Reinhard Dr Brueckner
Dieter Dr Ziegler
Elbert Dr Kaan
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of DK0689837T3 publication Critical patent/DK0689837T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dental Preparations (AREA)
  • Fats And Perfumes (AREA)
DK95109812T 1994-07-01 1995-06-23 Antihyoerglykæmisk aktive lægemidler DK0689837T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4423177A DE4423177A1 (de) 1994-07-01 1994-07-01 Antihyperglykämisch wirksame Arzneimittel

Publications (1)

Publication Number Publication Date
DK0689837T3 true DK0689837T3 (da) 2002-03-11

Family

ID=6522064

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95109812T DK0689837T3 (da) 1994-07-01 1995-06-23 Antihyoerglykæmisk aktive lægemidler

Country Status (23)

Country Link
US (1) US5712283A (fr)
EP (1) EP0689837B1 (fr)
JP (1) JP3841846B2 (fr)
KR (1) KR100366130B1 (fr)
CN (1) CN1092961C (fr)
AT (1) ATE210444T1 (fr)
AU (1) AU691580B2 (fr)
CA (1) CA2152998C (fr)
CZ (1) CZ287563B6 (fr)
DE (2) DE4423177A1 (fr)
DK (1) DK0689837T3 (fr)
DZ (1) DZ1894A1 (fr)
ES (1) ES2167385T3 (fr)
FI (1) FI117374B (fr)
HU (1) HU226946B1 (fr)
IL (1) IL113411A (fr)
NO (1) NO307029B1 (fr)
NZ (1) NZ270990A (fr)
PT (1) PT689837E (fr)
RU (1) RU2145857C1 (fr)
SK (1) SK282227B6 (fr)
UA (1) UA27954C2 (fr)
ZA (1) ZA954691B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977121A (en) * 1995-02-28 1999-11-02 Eli Lilly And Company Use of moxonidine for the treatment of atherosclerosis
ZA974978B (en) * 1996-06-06 1998-12-07 Lilly Co Eli Formulation and method for treating congestive heart failure
IL123232A0 (en) * 1997-02-11 1999-11-30 Lilly Co Eli Medicament for inhibiting glucose metabolism deterioration
DE19722322A1 (de) * 1997-05-28 1998-12-03 Solvay Pharm Gmbh Nephroprotektives Arzneimittel
JP2001520195A (ja) * 1997-10-17 2001-10-30 イーライ・リリー・アンド・カンパニー 医薬の増強
US6897019B1 (en) 1998-04-17 2005-05-24 Tufts College Methods for treating and preventing insulin resistance and related disorders
AU2727400A (en) * 1999-01-29 2000-08-18 Eli Lilly And Company Moxonidine salts
DE19911371A1 (de) 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
AU2003257418A1 (en) * 2002-06-19 2004-01-06 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
KR101137084B1 (ko) * 2003-10-10 2012-04-24 애보트 프러덕츠 게엠베하 셀렉티브 ⅰ１ 이미다졸린 수용체 작용제 및 엔지오텐신 ⅱ수용체 차단제를 포함하는 약학적 조성물
RU2542462C2 (ru) * 2013-06-28 2015-02-20 Андрей Владиславович Струтынский Способ коррекции кризового течения гипертонической болезни и абдоминального ожирения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2849537C2 (de) * 1978-11-15 1983-03-17 Beiersdorf Ag, 2000 Hamburg Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
FR2669927B1 (fr) * 1990-11-29 1994-04-08 Adir Cie Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
CN1122224A (zh) 1996-05-15
ES2167385T3 (es) 2002-05-16
NO952624L (no) 1996-01-02
FI953256A (fi) 1996-01-02
ATE210444T1 (de) 2001-12-15
CZ139395A3 (en) 1996-01-17
NO307029B1 (no) 2000-01-31
DZ1894A1 (fr) 2002-02-17
CA2152998C (fr) 2002-09-03
FI953256A0 (fi) 1995-06-30
HU9501900D0 (en) 1995-08-28
IL113411A (en) 1999-07-14
NO952624D0 (no) 1995-06-30
CA2152998A1 (fr) 1996-01-02
KR100366130B1 (ko) 2003-03-26
CN1092961C (zh) 2002-10-23
DE59509928D1 (de) 2002-01-24
SK74995A3 (en) 1996-05-08
PT689837E (pt) 2002-04-29
EP0689837A2 (fr) 1996-01-03
ZA954691B (en) 1996-01-29
HUT72599A (en) 1996-05-28
EP0689837A3 (fr) 1996-06-05
RU2145857C1 (ru) 2000-02-27
EP0689837B1 (fr) 2001-12-12
AU1775795A (en) 1996-01-18
SK282227B6 (sk) 2001-12-03
HU226946B1 (en) 2010-03-29
FI117374B (fi) 2006-09-29
JPH0840906A (ja) 1996-02-13
US5712283A (en) 1998-01-27
AU691580B2 (en) 1998-05-21
CZ287563B6 (en) 2000-12-13
NZ270990A (en) 1997-06-24
DE4423177A1 (de) 1996-01-04
JP3841846B2 (ja) 2006-11-08
UA27954C2 (uk) 2000-10-16
KR960003729A (ko) 1996-02-23
IL113411A0 (en) 1995-07-31

Similar Documents

Publication Publication Date Title
DE59010810D1 (de) Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
EE02971B1 (et) Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks
ES2139638T3 (es) 1,4-piperazinas disustituidas para el tratamiento de las enfermedades del sistema nervioso central y de las enfermedades neuroendocrinas.
ATE87481T1 (de) Orale arzneimittelformen von pimobendan.
ATE81009T1 (de) N-acetyl-3-fluoroneuraminsaeure als antivirales arzneimittel.
DK0689837T3 (da) Antihyoerglykæmisk aktive lægemidler
DE69231298T2 (de) Substituierte Dibenzoxazepinverbindungen, pharmazeutische Zusammensetzungen und Anwendungsmethoden
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
EP0369887A3 (fr) Utilisation de trifluorométhylphényltétrahydropyridines pour la préparation de médicaments destinés à combattre les troubles anxio-dépressifs
EP0330052A3 (fr) Utilisation de benzimidazoles pour la préparation de médicaments à activité anti-ischémique cardiaque et combinaisons avec des bêta-bloquants ou des agents bradycardisants
DE10299023I1 (de) Antineoplastisch wirkender und den Antineoplastischen effekt Verstaerkender Wirkstoff
EP0471388A3 (fr) Médicament pour le traitement de l'insuffisance cardiaque
GR861646B (en) 4-amino-2-(imidazolidin-2-on-1-yl)-pyrimidino-5-carbonic acid -(n-triphthoro - methyl-phenyl)-amides for antithrombotic protection and treatment use and preparation of antithrombotically active medicines
DE69106276D1 (de) Säureadditionssalze einer optisch aktiven Alaninanilidverbindung und diese enthaltende, pharmazeutische Zusammensetzungen.
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
ATE138805T1 (de) Substituiertes benzofuranylpiperidin als nootropikum
JPS6434920A (en) Therapy for mycobacterium abium intracellular complex infection
DE3674060D1 (de) Pharmacologisch aktive propionylanilide.
ITRM920173A1 (it) Composizione a base di ibuprofen per uso orale.